Clinical Trial Update: Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether low molecular weight heparin and/or aspirin can prevent habitual abortion (recurrent pregnancy loss); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• Aspirin (Aspirin)
• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: University of Helsinki | Conditions: Habitual Abortion | Phase 3 | Status: COMPLETED